Name: Recombinant Human soluble Fas Receptor/TNFRSF6 (Human sFasR/TNFRSF6)_C230488
Brand: Arcegen
SKU: C230488E
Price: 74.0 USD

Recombinant Human soluble Fas Receptor/TNFRSF6 (Human sFasR/TNFRSF6)_C230488

Product form

Size

SKU: C230488E

$74.00

Synonyms	TNFRSF6, CD95, Apo I, Fas Antigen
Accession	P25445
GeneID	355
Source	E.coli-derived Human sFasR/TNFRSF6 protein,Arg17-Asn173.
Molecular Weight	Approximately 17.6 kDa.
AA Sequence	RLSSKSVNAQ VTDINSKGLE LRKTVTTVET QNLEGLHHDG QFCHKPCPPG ERKARDCTVN GDEPDCVPCQ EGKEYTDKAH FSSKCRRCRL CDEGHGLEVE INCTRTQNTK CRCKPNFFCN STVCEHCDPC TKCEHGIIKE CTLTSNTKCK EEGSRSN
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	> 95 % by SDS-PAGE and HPLC analyses.
Biological Activity	Fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 µg/mL in the presence of 2 ng/mLof rHuFas Ligand.
Endotoxin	Less than 1.0 EU/μg of the protein as determined by LAL method.
Formulation	Lyophilized from a 0.2 mm filtered concentrated solution in 20 mM PB, pH 7.4, 150 mM NaCl.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom.Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.

Synonyms	TNFRSF6, CD95, Apo I, Fas Antigen
Accession	P25445
GeneID	355
Source	E.coli-derived Human sFasR/TNFRSF6 protein,Arg17-Asn173.
Molecular Weight	Approximately 17.6 kDa.
AA Sequence	RLSSKSVNAQ VTDINSKGLE LRKTVTTVET QNLEGLHHDG QFCHKPCPPG ERKARDCTVN GDEPDCVPCQ EGKEYTDKAH FSSKCRRCRL CDEGHGLEVE INCTRTQNTK CRCKPNFFCN STVCEHCDPC TKCEHGIIKE CTLTSNTKCK EEGSRSN
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	> 95 % by SDS-PAGE and HPLC analyses.
Biological Activity	Fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 µg/mL in the presence of 2 ng/mLof rHuFas Ligand.
Endotoxin	Less than 1.0 EU/μg of the protein as determined by LAL method.
Formulation	Lyophilized from a 0.2 mm filtered concentrated solution in 20 mM PB, pH 7.4, 150 mM NaCl.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom.Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.